|
US4443340A
(en)
|
1981-10-09 |
1984-04-17 |
Betz Laboratories, Inc. |
Control of iron induced fouling in water systems
|
|
US5100899A
(en)
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
|
JPH04230389A
(ja)
|
1990-07-16 |
1992-08-19 |
American Home Prod Corp |
ラパマイシン誘導体
|
|
US5023262A
(en)
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
|
ZA924953B
(en)
|
1991-07-25 |
1993-04-28 |
Univ Louisville Res Found |
Method of treating ocular inflammation
|
|
WO1993012160A1
(fr)
|
1991-12-19 |
1993-06-24 |
Mitsui Toatsu Chemicals, Inc. |
Acide polyhydroxy carboxylique et son procede de production
|
|
US5177203A
(en)
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
|
US5242910A
(en)
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
|
US5536729A
(en)
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5527907A
(en)
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
WO1996039995A1
(en)
*
|
1995-06-07 |
1996-12-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5989591A
(en)
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
|
ATE427760T1
(de)
|
2001-02-23 |
2009-04-15 |
Genentech Inc |
Erodierbare polymere zur injektion
|
|
US8501215B2
(en)
|
2002-07-31 |
2013-08-06 |
Guohua Chen |
Injectable multimodal polymer depot compositions and uses thereof
|
|
WO2004027027A2
(en)
|
2002-09-18 |
2004-04-01 |
Trustees Of The University Of Pennsylvania |
Method of inhibiting choroidal neovascularization
|
|
DE60325511D1
(de)
|
2002-11-06 |
2009-02-05 |
Alza Corp |
Depot-formulierungen mit verzögerter freisetzung
|
|
SI1575569T1
(sl)
|
2002-12-13 |
2010-12-31 |
Durect Corp |
Oralni sistem dostave zdravila, ki obsega visokoviskozne tekoče nosilne materiale
|
|
WO2004081196A2
(en)
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
|
AU2004274026A1
(en)
|
2003-09-18 |
2005-03-31 |
Macusight, Inc. |
Transscleral delivery
|
|
US7087237B2
(en)
*
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
EP3103477A1
(en)
*
|
2004-09-17 |
2016-12-14 |
Durect Corporation |
Sustained local anesthetic composition containing saib
|
|
CN101890167B
(zh)
|
2004-10-01 |
2017-03-01 |
拉姆斯科股份有限公司 |
可方便植入的缓释药物组合物
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
CA2597590A1
(en)
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
AU2006227116A1
(en)
|
2005-03-21 |
2006-09-28 |
Santen Pharmaceutical Co., Ltd. |
Drug delivery systems for treatment of diseases or conditions
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
WO2007092620A2
(en)
|
2006-02-09 |
2007-08-16 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
US8222271B2
(en)
|
2006-03-23 |
2012-07-17 |
Santen Pharmaceutical Co., Ltd. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
CN1973822A
(zh)
|
2006-12-20 |
2007-06-06 |
山东蓝金生物工程有限公司 |
一种含雷帕霉素的抗癌组合物
|
|
ES2447516T3
(es)
|
2006-12-21 |
2014-03-12 |
Stryker Corporation |
Formulaciones de liberación sostenida que comprenden cristales BMP-7
|
|
WO2008143992A2
(en)
|
2007-05-18 |
2008-11-27 |
Durect Corporation |
Improved depot formulations
|
|
ES2507078T3
(es)
*
|
2007-08-16 |
2014-10-14 |
Santen Pharmaceutical Co., Ltd |
Formulaciones de rapamicina para tratamiento de la degeneración macular relacionada con la edad
|
|
EP3326621A1
(en)
|
2007-12-06 |
2018-05-30 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
JP5737949B2
(ja)
*
|
2008-02-08 |
2015-06-17 |
キューピーエス リミテッド ライアビリティ カンパニー |
薬物制御送達用の非ポリマー組成物
|
|
US20120114637A1
(en)
|
2009-05-04 |
2012-05-10 |
Santen Pharmaceutical Co., Ltd. |
Mtor pathway inhibitors for treating ocular disorders
|
|
CA2812102A1
(en)
*
|
2010-11-24 |
2012-06-07 |
Durect Corporation |
Biodegradable drug delivery composition
|
|
TW201334791A
(zh)
|
2011-11-23 |
2013-09-01 |
杜瑞克公司 |
輻射滅菌之可生物降解之藥物遞送組合物
|
|
KR20220044379A
(ko)
|
2012-01-23 |
2022-04-07 |
알러간, 인코포레이티드 |
고화 디포-형성 주사가능 약물 제형에 현탁된 서방형 생분해성 또는 생체흡수성 미소구체 또는 미립자
|
|
JP2016512523A
(ja)
|
2013-03-11 |
2016-04-28 |
デュレクト コーポレーション |
高粘性液体キャリアを含む注射用制御放出組成物
|
|
US20160038479A1
(en)
|
2013-03-15 |
2016-02-11 |
Durect Corporation |
Compositions with Thixotropy and Enhanced Dissolution Reproducibility and Stability
|
|
US9572885B2
(en)
|
2013-03-15 |
2017-02-21 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
CN105407896B
(zh)
|
2013-05-24 |
2019-08-27 |
爱康生物科技有限公司 |
缓释的地塞米松在白内障手术后的炎症中的应用
|
|
CN107249570B
(zh)
|
2014-11-21 |
2022-08-09 |
丹麦技术大学 |
用于局部药物释放的凝胶制剂
|
|
TWI731853B
(zh)
|
2015-03-18 |
2021-07-01 |
日商參天製藥股份有限公司 |
徐放性醫藥組成物及其安定化方法
|
|
WO2017002941A1
(ja)
|
2015-07-01 |
2017-01-05 |
参天製薬株式会社 |
クエン酸エステルを含有するデポ剤
|
|
TWI765898B
(zh)
|
2016-06-30 |
2022-06-01 |
美商杜瑞克公司 |
儲積調製劑
|
|
CA3049543A1
(en)
|
2017-01-06 |
2018-07-12 |
Santen Pharmaceutical Co., Ltd. |
Intratumoral administration of sirolimus for treatment of prostate cancer
|